» Articles » PMID: 34645481

The Decreased Platelet-to-lymphocyte Ratio Could Predict a Good Prognosis in Patients with Oligometastatic Colorectal Cancer: a Single-center Cohort Retrospective Study

Overview
Publisher Biomed Central
Date 2021 Oct 14
PMID 34645481
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inflammation markers have an important effect on tumor proliferation, invasion, and metastasis. Oligometastatic disease (OMD) is an intermediate state between widespread metastases and locally confined disease, where curative strategies may be effective for some patients. We aimed to explore the predictive value of inflammatory markers in patients with oligometastatic colorectal cancer (OMCC) and build a nomogram to predict the prognosis of these patients.

Methods: Two hundred nine patients with OMCC were retrospectively collected in this study. The Kaplan-Meier survival curves and Cox regression analysis were used to estimate overall survival (OS) and progression-free survival (PFS). A multivariate Cox analysis model was utilized to establish the nomogram. The concordance index (C-index), calibration curve, and receiver operating characteristics (ROC) were established to verify the validity and accuracy of the prediction model.

Results: According to the multivariate analysis, decreased platelet-to-lymphocyte ratio (PLR) might independently improve OS in patients with OMCC (HR = 2.396, 95% CI 1.391-4.126, P = 0.002). Metastases of extra-regional lymph nodes indicated poor OS (HR = 2.472, 95% CI 1.247-4.903, P = 0.010). While the patients with early N stage had better OS (HR = 4.602, 95% CI 2.055-10.305, P = 0.001) and PFS (HR = 2.100, 95% CI 1.364-3.231, P = 0.007). Primary tumor resection (HR = 0.367, 95% CI 0.148-0.908, P = 0.030) and lower fibrinogen (HR = 2.254, 95% CI 1.246-4.078, P = 0.007) could significantly prolong the OS in patients with OMCC. PLR, metastases of extra-regional lymph nodes, N stage, primary tumor resection, and fibrinogen were used to make up the nomogram. The C-index and area under the curve (AUC) of the ROC in nomogram were 0.721 and 0.772 respectively for OS, showed good consistency between predictive probability of OS and actual survival.

Conclusions: Decreased PLR could predict a good prognosis in patients with OMCC. The nomogram including inflammatory factors and clinicopathological markers was credible and accurate to predict survivals in patients with OMCC.

Citing Articles

Complete blood counts as potential risk factors of early dissemination to liver and lungs in resected colorectal cancer: a retrospective cohort study.

Popeda M, Zok J, Tomasik B, Duchnowska R, Bienkowski M Int J Colorectal Dis. 2025; 40(1):21.

PMID: 39836241 PMC: 11750913. DOI: 10.1007/s00384-024-04802-9.


Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma Multiforme.

Zemskova O, Yu N, Loser A, Leppert J, Rades D Cancer Diagn Progn. 2024; 4(4):408-415.

PMID: 38962535 PMC: 11215454. DOI: 10.21873/cdp.10340.


Emerging Role of Tumor-Educated Platelets as a New Liquid Biopsy Tool for Colorectal Cancer.

Razzaghi H, Khabbazpour M, Heidary Z, Heiat M, Shirzad Moghaddam Z, Derogar P Arch Iran Med. 2024; 26(8):447-454.

PMID: 38301107 PMC: 10685733. DOI: 10.34172/aim.2023.68.


Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis.

Sugimoto A, Fukuoka T, Shibutani M, Kasashima H, Kitayama K, Ohira M BMC Gastroenterol. 2023; 23(1):88.

PMID: 36966294 PMC: 10040130. DOI: 10.1186/s12876-023-02722-6.


Prognostic factors in colorectal liver metastases patients with various tumor numbers treated by liver resection: a single-center, retrospective study.

Chen F, Wang Y, Liu W, Xing B World J Surg Oncol. 2022; 20(1):237.

PMID: 35854361 PMC: 9297581. DOI: 10.1186/s12957-022-02700-4.


References
1.
Trellakis S, Bruderek K, Dumitru C, Gholaman H, Gu X, Bankfalvi A . Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2010; 129(9):2183-93. DOI: 10.1002/ijc.25892. View

2.
Huitzil-Melendez F, Capanu M, OReilly E, Duffy A, Gansukh B, Saltz L . Advanced hepatocellular carcinoma: which staging systems best predict prognosis?. J Clin Oncol. 2010; 28(17):2889-95. PMC: 3651603. DOI: 10.1200/JCO.2009.25.9895. View

3.
Iimori N, Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K . Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer. In Vivo. 2018; 32(3):669-675. PMC: 6000781. DOI: 10.21873/invivo.11292. View

4.
Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng H . Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol. 2016; 14(1):289. PMC: 5112720. DOI: 10.1186/s12957-016-1044-9. View

5.
Van Cutsem E, Cervantes A, Nordlinger B, Arnold D . Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014; 25 Suppl 3:iii1-9. DOI: 10.1093/annonc/mdu260. View